OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment of Metastatic Melanoma in the Elderly
Rino S. Seedor, Marlana Orloff
Current Oncology Reports (2022) Vol. 24, Iss. 7, pp. 825-833
Closed Access | Times Cited: 14
Rino S. Seedor, Marlana Orloff
Current Oncology Reports (2022) Vol. 24, Iss. 7, pp. 825-833
Closed Access | Times Cited: 14
Showing 14 citing articles:
ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway in melanoma
Min Wang, Guang Zeng, Bingrui Xiong, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115554-115554
Closed Access | Times Cited: 18
Min Wang, Guang Zeng, Bingrui Xiong, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115554-115554
Closed Access | Times Cited: 18
A Single Institution Experience Using Ultrasound-Guided Intralesional Immunotherapy in Recurrent Melanoma
Olivia P. Waldron, Joanna T. Buchheit, Colette R. Pameijer
Surgical Oncology Insight (2025), pp. 100130-100130
Open Access
Olivia P. Waldron, Joanna T. Buchheit, Colette R. Pameijer
Surgical Oncology Insight (2025), pp. 100130-100130
Open Access
Melanoma in Special Populations
Aikaterini Dedeilia, Tobias Braun, Genevieve M. Boland
Surgical Clinics of North America (2025)
Closed Access
Aikaterini Dedeilia, Tobias Braun, Genevieve M. Boland
Surgical Clinics of North America (2025)
Closed Access
Artificial intelligence-assisted metastasis and prognosis model for patients with nodular melanoma
Chan Xu, Xiaoyu Yu, Zhendong Ding, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0305468-e0305468
Open Access | Times Cited: 2
Chan Xu, Xiaoyu Yu, Zhendong Ding, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0305468-e0305468
Open Access | Times Cited: 2
HOXB9 a miR-122–5p regulated gene, suppressed the anticancer effects of brusatol by upregulating SCD1 expression in melanoma
Ziming Guo, Na Li, Yuankuan Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114650-114650
Open Access | Times Cited: 4
Ziming Guo, Na Li, Yuankuan Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114650-114650
Open Access | Times Cited: 4
Risk factors and predictive models for early death in patients with advanced melanoma: A population-based study
Siru Li, Cunli Yin, Xi Yang, et al.
Medicine (2023) Vol. 102, Iss. 40, pp. e35380-e35380
Open Access | Times Cited: 4
Siru Li, Cunli Yin, Xi Yang, et al.
Medicine (2023) Vol. 102, Iss. 40, pp. e35380-e35380
Open Access | Times Cited: 4
A novel tool for predicting the risk of cancer-specific early death in older patients with primary malignant melanoma of skin: a population-based analysis
Lei Yan, Shucui Wang, Jun Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Lei Yan, Shucui Wang, Jun Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Bioinformatics data combined with single-cell analysis reveals patterns of immunoinflammatory infiltration and cell death in melanoma
Li Jin, Ge Yang, Yangying Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113347-113347
Closed Access | Times Cited: 1
Li Jin, Ge Yang, Yangying Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113347-113347
Closed Access | Times Cited: 1
A Bibliometric Analysis of Melanoma Treated with Vaccinations Research from 2013 to 2023: A Comprehensive Review of the Literature
Xinyu Wang, Qiannan Jia, Mengyin Wu, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1113-1113
Open Access | Times Cited: 3
Xinyu Wang, Qiannan Jia, Mengyin Wu, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1113-1113
Open Access | Times Cited: 3
Correlation Analyses between Histological Staging and Molecular Alterations in Tumor-Derived and Cell-Free DNA of Early-Stage Primary Cutaneous Melanoma
Szilvia Lilla Csoma, Kristóf Madarász, Yi Che Chang Chien, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5141-5141
Open Access | Times Cited: 2
Szilvia Lilla Csoma, Kristóf Madarász, Yi Che Chang Chien, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5141-5141
Open Access | Times Cited: 2
[Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Siru Li, Jing Li, Qi Yang, et al.
PubMed (2024) Vol. 55, Iss. 2, pp. 367-374
Closed Access
Siru Li, Jing Li, Qi Yang, et al.
PubMed (2024) Vol. 55, Iss. 2, pp. 367-374
Closed Access
The Roles of Cytoplasmic Polyadenylation Element Binding Protein 1 in Tumorigenesis
Jiayi Li, Yinxin Wu, D. H. Zhang, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 22, pp. 2008-2018
Closed Access
Jiayi Li, Yinxin Wu, D. H. Zhang, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 22, pp. 2008-2018
Closed Access
The Utilization of PRAME in the Diagnosis, Prognosis, and Treatment of Melanoma
S. Blount, Xiaochen Liu, Jeffrey D. McBride
Cells (2024) Vol. 13, Iss. 20, pp. 1740-1740
Open Access
S. Blount, Xiaochen Liu, Jeffrey D. McBride
Cells (2024) Vol. 13, Iss. 20, pp. 1740-1740
Open Access
Upgrading Melanoma Treatment: Promising Immunotherapies Combinations in the Preclinical Mouse Model
Israel Lara-Vega
Current Cancer Therapy Reviews (2023) Vol. 20, Iss. 5, pp. 489-509
Closed Access
Israel Lara-Vega
Current Cancer Therapy Reviews (2023) Vol. 20, Iss. 5, pp. 489-509
Closed Access
